Regarding the correlation between cervical cancer and SGLT2 inhibitors, the previous experimental research and bioinformatic analysis demonstrated that the application of SGLT2 inhibitors can reduce the cervical cancer cell growth and migration 27-29, 37, 38. The gene discussed is SLC5A2; the disease is cervical carcinoma.